Samba biosimba: Brazil to make local Enbrel
This article was originally published in Scrip
Brazil's biggest local companies, Ache, Uniao Quimica, Hypermarcas and EMS, under the name Bionovis, and two state owned labs, Fiocruz and Vital Brasil, are getting together to produce what authorities laud as the first ever 100% Brazilian biologic, a biosimilar of Pfizer/Amgen's Enbrel (etanercept). Similar announcements could follow as the government tries to cut costs by buying locally produced versions of expensive imported biologics, says Benny Spiewak from the law firm ZCBS Advogados.
You may also be interested in...
WTO member states including the EU, the US and the UK argue that waiving certain IP rights is unnecessary for enhancing responses to the Covid-19 pandemic.
Insurers argue that better use of real world data and multiple pricing assessments could help lower drug prices in Germany.
To keep investors happy, companies will have to start showing that their high-priced advanced therapies offset costs elsewhere in the health care system.